Agilent Licenses Roche's Melting Curve Analysis Technology for PCR Applications | GenomeWeb
NEW YORK (GenomeWeb News) – Roche Diagnostics said today that it has granted a non-exclusive license of its melting curve analysis technology to Agilent Technologies
 
Under the agreement, Agilent has acquired the rights to use, develop, and sell products that are based on Roche’s melting curve analysis technique, which is used in analyzing DNA in the PCR process.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Wall Street Journal reports that National Institutes of Health Director Francis Collins' response to contamination concerns at the agency might have delayed care.

The final revision of the Common Rule doesn't include the proposed change requiring consent for leftover biospecimens.

The first Reproducibility Project: Cancer Biology papers show mixed results.

In Nature this week: mobile phone-based targeted DNA sequencing, and more.